SCHEMBL19040969

SCHEMBL19040969

CCN(/C=C(\C(=O)C(F)(F)F)c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
GLA P06280 1/20 0.39
TSHR P16473 1/20 0.39
MLYCD O95822 2/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
CES1 P23141 1/20 0.39
CYP2C19 P33261 2/20 0.37
HTT P42858 1/20 0.36
HPGD P15428 1/20 0.36
PGR P06401 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
HTR2A P28223 1/20 0.36
HRH1 P35367 1/20 0.36
KCNH2 Q12809 1/20 0.36
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19028025 1.00 ALDH1A1 (0.39) ALDH1A1GLATSHRMLYCDCA12
SCHEMBL19028024 1.00 ALDH1A1 (0.39) ALDH1A1GLATSHRMLYCDCA12
SCHEMBL19041194 0.97 CA12 (0.41) ALDH1A1GLATSHRMLYCDCA12
SCHEMBL19041197 0.97 ALDH1A1 (0.39) ALDH1A1GLATSHRMLYCDCA12
SCHEMBL19041207 0.93 MLYCD (0.36) ALDH1A1GLATSHRMLYCDCA12
SCHEMBL19041154 0.92 KMT2A (0.38) ALDH1A1GLATSHRMLYCDCA12
SCHEMBL19796017 0.92 CA12 (0.39) ALDH1A1CA12CA1CA2CA9
SCHEMBL19795937 0.92 CA12 (0.38) ALDH1A1MLYCDCA12CA1CA2
SCHEMBL19795935 0.92 MLYCD (0.36) ALDH1A1GLATSHRMLYCDCA12
SCHEMBL19041106 0.92 CA2 (0.39) ALDH1A1GLATSHRMLYCDCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180022693-A1 COMPOUNDS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2018-01-25 US disclosed
WO-2017106930-A1 COMPOUNDS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2017-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180022693-A1 COMPOUNDS ERCC4, NQO1, ERCC5 ALDH1A1 981/4885GLA 2077/4885TSHR 3898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.